CoChat

Human Vascular Microphysiological System for in vitro Drug Screening

Open access
Fernandez, C. E., Yen, R. W., Perez, S. M., Bedell, H. W., Povsic, T. J., Reichert, W. M., Truskey, G. A. · 2016 · Scientific Reports

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Abstract

In vitro human tissue engineered human blood vessels (TEBV) that exhibit vasoactivity can be used to test human toxicity of pharmaceutical drug candidates prior to pre-clinical animal studies. TEBVs with 400–800 μM diameters were made by embedding human neonatal dermal fibroblasts or human bone marrow-derived mesenchymal stem cells in dense collagen gel. TEBVs were mechanically strong enough to allow endothelialization and perfusion at physiological shear stresses within 3 hours after fabrication. After 1 week of perfusion, TEBVs exhibited endothelial release of nitric oxide, phenylephrine-induced vasoconstriction and acetylcholine-induced vasodilation, all of which were maintained up to 5 weeks in culture. Vasodilation was blocked with the addition of the nitric oxide synthase inhibitor L-N G-Nitroarginine methyl ester (L-NAME). TEBVs elicited reversible activation to acute inflammatory stimulation by TNF-α which had a transient effect upon acetylcholine-induced relaxation and exhibited dose-dependent vasodilation in response to caffeine and theophylline. Treatment of TEBVs with 1 μM lovastatin for three days prior to addition of Tumor necrosis factor – α (TNF-α) blocked the injury response and maintained vasodilation. These results indicate the potential to develop a rapidly-producible, endothelialized TEBV for microphysiological systems capable of producing physiological responses to both pharmaceutical and immunological stimuli.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep21579

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 TEBV Fabrication and Culture. A suspension of hNDFs in collagen is poured into the mold containing an 810-μm diameter mandrel and allowed to gel for 30 minutes (a). Collagen fiber density increases through plastic compression and removal of water (b). Compressed TEBVs are immediately mounted in custom chambers (c). CAD EPCs are seeded into the lumen of the TEBV (d) and the chamber is rotated at 10 rph for 30 minutes (e). After endothelialization, TEBVs are mounted into the perfusion circuit and cultured for at least 1 week at a flow rate of 2 mL/min (f). TEBVs before (g) and after compression (h). Live-dead assay performed 24 hours after compression (i). H&E cross-section of TEBV after 1 week of perfusion culture (j). Scale bars indicate 200 μm unless otherwise noted.
Figure 1 TEBV Fabrication and Culture. A suspension of hNDFs in collagen is poured into the mold containing an 810-μm diameter mandrel and allowed to gel for 30 minutes (a). Collagen fiber density increases through plastic compression and removal of water (b). Compressed TEBVs are immediately mounted in custom chambers (c). CAD EPCs are seeded into the lumen of the TEBV (d) and the chamber is rotated at 10 rph for 30 minutes (e). After endothelialization, TEBVs are mounted into the perfusion circuit and cultured for at least 1 week at a flow rate of 2 mL/min (f). TEBVs before (g) and after compression (h). Live-dead assay performed 24 hours after compression (i). H&E cross-section of TEBV after 1 week of perfusion culture (j). Scale bars indicate 200 μm unless otherwise noted.CC BY · PubMed Central
Figure 2 TEBV Mechanical Properties and Stability. TEBVs comprised of collagen only maintained under static conditions for 24 hours demonstrated burst pressures of 1577.6 ± 54.5 mm Hg. TEBVs embedded with hNDFs and maintained under static conditions for 24 hours after preparation exhibited burst pressures of 1460.1 ± 28.8 mm Hg, but 1 week of culture under static conditions led to burst pressures of 1104.5 ± 77.1 mm Hg. Exposure to flow increased the mechanical properties of the TEBVs after 7 days, leading to burst pressures of 1552.6 ± 54.9 mm Hg. Endothelialized TEBVs perfused for 7 days yielded burst pressures of 1777.6 ± 15.8 mm Hg Values are reported as mean ± SEM, n = 3, 4 TEBVs. (*p < 0.05, ●p < 0.01, **p < 0.005, #p < 0.0001) (a). A one-way repeated measures ANOVA and the post-hoc Tukey test indicated that the inner diameter of endothelialized hNDF TEBVs stabilized after the second week in culture (*P < 0.05 with respect to weeks 2–5). The outer diameter stabilizes after the third week in culture (*P < 0.05 with respect to week 5; **P < 0.005 with respect to weeks 2 and 3; #P < 0.0001 with respect to weeks 4 and 5.) Values are mean ± SEM. Four independent experiments were conducted. (b).
Figure 2 TEBV Mechanical Properties and Stability. TEBVs comprised of collagen only maintained under static conditions for 24 hours demonstrated burst pressures of 1577.6 ± 54.5 mm Hg. TEBVs embedded with hNDFs and maintained under static conditions for 24 hours after preparation exhibited burst pressures of 1460.1 ± 28.8 mm Hg, but 1 week of culture under static conditions led to burst pressures of 1104.5 ± 77.1 mm Hg. Exposure to flow increased the mechanical properties of the TEBVs after 7 days, leading to burst pressures of 1552.6 ± 54.9 mm Hg. Endothelialized TEBVs perfused for 7 days yielded burst pressures of 1777.6 ± 15.8 mm Hg Values are reported as mean ± SEM, n = 3, 4 TEBVs. (*p < 0.05, ●p < 0.01, **p < 0.005, #p < 0.0001) (a). A one-way repeated measures ANOVA and the post-hoc Tukey test indicated that the inner diameter of endothelialized hNDF TEBVs stabilized after the second week in culture (*P < 0.05 with respect to weeks 2–5). The outer diameter stabilizes after the third week in culture (*P < 0.05 with respect to week 5; **P < 0.005 with respect to weeks 2 and 3; #P < 0.0001 with respect to weeks 4 and 5.) Values are mean ± SEM. Four independent experiments were conducted. (b).CC BY · PubMed Central
Figure 3 Expression of contractile and extracellular matrix proteins in endothelialized TEBVs. Perfusion for 1 week increased mRNA expression of α-SMA and calponin compared to TEBVs under static conditions. One-way ANOVAs with post-hoc Tukey’s tests were performed on the results of four independent experiments performed with hNDF-only TEBVs and hNDF TEBVs under flow and three independent experiments performed with endothelialized TEBVs matured for 1 week under physiological perfusion. (*p < 0.05, **p < 0.005; mean ± SEM). Calponin results were normalized to reference RNA derived from a TEBV matured under static conditions for 24 hours (a). Endothelialized TEBVs composed of hNDFs demonstrated greater expression of contractile proteins α-SMA and calponin after 1 week in perfusion culture (d,e), compared to endothelialized TEBVs composed of hMSCs (h,i). After 1 week of perfusion culture, endothelialized TEBVs composed of hNDFs produced more basement membrane proteins fibronectin (b), collagen IV (f), and laminin (j) than endothelialized TEBVs composed of hMSCs (c,g,k), respectively. All scale bars represent 100 μm.
Figure 3 Expression of contractile and extracellular matrix proteins in endothelialized TEBVs. Perfusion for 1 week increased mRNA expression of α-SMA and calponin compared to TEBVs under static conditions. One-way ANOVAs with post-hoc Tukey’s tests were performed on the results of four independent experiments performed with hNDF-only TEBVs and hNDF TEBVs under flow and three independent experiments performed with endothelialized TEBVs matured for 1 week under physiological perfusion. (*p < 0.05, **p < 0.005; mean ± SEM). Calponin results were normalized to reference RNA derived from a TEBV matured under static conditions for 24 hours (a). Endothelialized TEBVs composed of hNDFs demonstrated greater expression of contractile proteins α-SMA and calponin after 1 week in perfusion culture (d,e), compared to endothelialized TEBVs composed of hMSCs (h,i). After 1 week of perfusion culture, endothelialized TEBVs composed of hNDFs produced more basement membrane proteins fibronectin (b), collagen IV (f), and laminin (j) than endothelialized TEBVs composed of hMSCs (c,g,k), respectively. All scale bars represent 100 μm.CC BY · PubMed Central
Figure 4 TEBVs maintain endothelial coverage, nitric oxide (NO) production, and vasoactivity during 5 weeks of perfusion. Endothelialized TEBVs expressed vWF after 1 (a) and 5 weeks (b) and produced NO at similar rates after 1 and 5 weeks of perfusion (c). Endothelialized TEBVs elicit significantly more NO compared to TEBVs matured for one week without endothelium. Nitrates and nitrites were sampled from media perfused through TEBV for 48 hours and values represent mean ± SEM. NO from six hNDF-only TEBVs was measured in three independent experiments (N = 3) and from four independently cultured TEBVs measured at 1 and 5 weeks (N = 4). Four separate CAD EPC donors were evaluated and pooled. A one-way ANOVA with a post-hoc Tukey’s test indicates a significant effect of treatment on NO production (*P < 0.05), with respect to TEBVs without endothelium cultured for 1 week under perfusion (c). Endothelialized TEBVs elicit greater vasoconstriction to 1 μM phenylephrine after one week compared to endothelialized TEBVs with hNDFs and hMSCs (*P < 0.05 with respect to hNDF) (d). Endothelialized TEBVs composed of hNDFs maintain consistent vasoconstriction to 1 μM phenylephrine during 5 weeks of perfusion (e). A one-way repeated measures ANOVA indicated a significant effect of phenylephrine dose (P < 0.05, f). Endothelialized TEBVs composed of hNDFs or hMSCs elicited vasodilation to acetylcholine, compared to TEBVs without endothelium which constricted (●P < 0.01 and #P < 0.0001 compared to non-endothelialized hNDFs) (g). Endothelialized hNDF TEBVs maintained consistent vasodilation to acetylcholine over 5 weeks of perfusion (h). Endothelialized hNDF TEBVs perfused for 5 weeks elicited greater vasodilation in response to acetylcholine compared to endothelialized TEBVs perfused for 1 week. TEBVs cultured for 1 week without endothelium elicit increasing vasoconstriction in response to increasing doses of acetylcholine until 1 μM. TEBVs pre-treated with L-NAME exhibit constriction in response to increasing doses of acetylcholine (N = 4). Four hNDF-only TEBVs, four endothelialized TEBVs cultured for 1 week, and three endothelialized TEBVs cultured for 5 weeks were analyzed. A one-way repeated measures ANOVA confirmed a significant effect of acetylcholine dose (P < 0.0001). (i).
Figure 4 TEBVs maintain endothelial coverage, nitric oxide (NO) production, and vasoactivity during 5 weeks of perfusion. Endothelialized TEBVs expressed vWF after 1 (a) and 5 weeks (b) and produced NO at similar rates after 1 and 5 weeks of perfusion (c). Endothelialized TEBVs elicit significantly more NO compared to TEBVs matured for one week without endothelium. Nitrates and nitrites were sampled from media perfused through TEBV for 48 hours and values represent mean ± SEM. NO from six hNDF-only TEBVs was measured in three independent experiments (N = 3) and from four independently cultured TEBVs measured at 1 and 5 weeks (N = 4). Four separate CAD EPC donors were evaluated and pooled. A one-way ANOVA with a post-hoc Tukey’s test indicates a significant effect of treatment on NO production (*P < 0.05), with respect to TEBVs without endothelium cultured for 1 week under perfusion (c). Endothelialized TEBVs elicit greater vasoconstriction to 1 μM phenylephrine after one week compared to endothelialized TEBVs with hNDFs and hMSCs (*P < 0.05 with respect to hNDF) (d). Endothelialized TEBVs composed of hNDFs maintain consistent vasoconstriction to 1 μM phenylephrine during 5 weeks of perfusion (e). A one-way repeated measures ANOVA indicated a significant effect of phenylephrine dose (P < 0.05, f). Endothelialized TEBVs composed of hNDFs or hMSCs elicited vasodilation to acetylcholine, compared to TEBVs without endothelium which constricted (●P < 0.01 and #P < 0.0001 compared to non-endothelialized hNDFs) (g). Endothelialized hNDF TEBVs maintained consistent vasodilation to acetylcholine over 5 weeks of perfusion (h). Endothelialized hNDF TEBVs perfused for 5 weeks elicited greater vasodilation in response to acetylcholine compared to endothelialized TEBVs perfused for 1 week. TEBVs cultured for 1 week without endothelium elicit increasing vasoconstriction in response to increasing doses of acetylcholine until 1 μM. TEBVs pre-treated with L-NAME exhibit constriction in response to increasing doses of acetylcholine (N = 4). Four hNDF-only TEBVs, four endothelialized TEBVs cultured for 1 week, and three endothelialized TEBVs cultured for 5 weeks were analyzed. A one-way repeated measures ANOVA confirmed a significant effect of acetylcholine dose (P < 0.0001). (i).CC BY · PubMed Central
Figure 5 TEBVs perfused for one week elicit dose-dependent vasodilation in response to caffeine (A) and theophylline (B). A two-way repeated measures ANOVA demonstrates a significant effect of dose and the presence of the endothelium in response to caffeine (#p < 0.05). Data reported as mean ± SEM, n = 3 TEBVs (a). TEBVs exhibit dose-dependent vasodilation in response to theophylline. A one-way repeated measures ANOVA demonstrates a significant effect of dose (P < 0.05). Data reported as mean ± SEM, n = 6 TEBVs tested in three independent experiments (b).
Figure 5 TEBVs perfused for one week elicit dose-dependent vasodilation in response to caffeine (A) and theophylline (B). A two-way repeated measures ANOVA demonstrates a significant effect of dose and the presence of the endothelium in response to caffeine (#p < 0.05). Data reported as mean ± SEM, n = 3 TEBVs (a). TEBVs exhibit dose-dependent vasodilation in response to theophylline. A one-way repeated measures ANOVA demonstrates a significant effect of dose (P < 0.05). Data reported as mean ± SEM, n = 6 TEBVs tested in three independent experiments (b).CC BY · PubMed Central
Figure 6 Characterization of acute inflammatory response of TEBV endothelium. Endothelialized TEBVs elicit 5.1 ± 0.6% (mean ± SEM, N = 3 independent experiments. EPCs from 3 CAD donors were used and responses were pooled) dilation in response to 1 μM acetylcholine after 7 days of culture under laminar perfusion; however, after exposure to 200 U/mL TNF-α for 4.5 hours, TEBVs demonstrated an average vasoconstriction of −0.4 ± 0.3%. Three days after the removal of TNF-α, TEBVs demonstrated 3.3 ± 0.5% vasodilation in response to acetylcholine. Seven days after the removal of the TNF-α, TEBVs exhibited normal vasodilation in response to acetylcholine of 5.5 ± 0.5%, indicating that the endothelium is capable of recovering from an acute inflammatory stimulus. A one-way ANOVA indicates a significant effect of treatment day (P < 0.0001). A post-hoc Tukey’s test indicates a statistically significant drop in dilation in response to acetylcholine with TNF-α treatment (**P < 0.005 with respect to Day 7 + 4.5h TNF-α). (a). Treatment with 200 U/mL TNF-α for 4.5 hours increased the rate of nitric oxide within the TEBV circuit measured after perfusion for 48 hours (*p < 0.05) (b). Treatment with 200 U/mL TNF-α resulted in increased expression of ICAM-1 mRNA in hNDFs (c). En face images of TEBV endothelium demonstrate limited basal expression of cell adhesion molecules VCAM-1 (d), E-selectin (e), and ICAM-1 (f). Treatment with 200 U/mL TNF-α for 4.5 hours increases the expression of VCAM-1 (g), E-selectin (h), and ICAM-1 (i).
Figure 6 Characterization of acute inflammatory response of TEBV endothelium. Endothelialized TEBVs elicit 5.1 ± 0.6% (mean ± SEM, N = 3 independent experiments. EPCs from 3 CAD donors were used and responses were pooled) dilation in response to 1 μM acetylcholine after 7 days of culture under laminar perfusion; however, after exposure to 200 U/mL TNF-α for 4.5 hours, TEBVs demonstrated an average vasoconstriction of −0.4 ± 0.3%. Three days after the removal of TNF-α, TEBVs demonstrated 3.3 ± 0.5% vasodilation in response to acetylcholine. Seven days after the removal of the TNF-α, TEBVs exhibited normal vasodilation in response to acetylcholine of 5.5 ± 0.5%, indicating that the endothelium is capable of recovering from an acute inflammatory stimulus. A one-way ANOVA indicates a significant effect of treatment day (P < 0.0001). A post-hoc Tukey’s test indicates a statistically significant drop in dilation in response to acetylcholine with TNF-α treatment (**P < 0.005 with respect to Day 7 + 4.5h TNF-α). (a). Treatment with 200 U/mL TNF-α for 4.5 hours increased the rate of nitric oxide within the TEBV circuit measured after perfusion for 48 hours (*p < 0.05) (b). Treatment with 200 U/mL TNF-α resulted in increased expression of ICAM-1 mRNA in hNDFs (c). En face images of TEBV endothelium demonstrate limited basal expression of cell adhesion molecules VCAM-1 (d), E-selectin (e), and ICAM-1 (f). Treatment with 200 U/mL TNF-α for 4.5 hours increases the expression of VCAM-1 (g), E-selectin (h), and ICAM-1 (i).CC BY · PubMed Central
Figure 7 TEBV response to lovastatin, Endothelialized TEBVs cultured for 7 days and then exposed to 1 μM lovastatin for 3 days, or maintained without statin. On Day 10, TEBVs were exposed to 200 U/mL TNF-α for 4.5 hours, then exposed to 1 μM phenylephrine followed by 1 μM acetylcholine. Treatment with lovastatin demonstrated no effect on the endothelium-independent vasoconstriction in response to phenylephrine (a). Treatment with lovastatin substantially preserved the endothelium-dependent vasodilation response. A one-way repeated measures ANOVA and a post-hoc Dunnett’s test with respect to Day 10 post-TNF-α showed that while TNF-α treatment reduced vasodilation in the absence of statin (*P < 0.05, **P < 0.005) relative to conditions not exposed to TNF- α or statin, lovastatin treatment blocked the effect of TNF-α on vasodilation (b).
Figure 7 TEBV response to lovastatin, Endothelialized TEBVs cultured for 7 days and then exposed to 1 μM lovastatin for 3 days, or maintained without statin. On Day 10, TEBVs were exposed to 200 U/mL TNF-α for 4.5 hours, then exposed to 1 μM phenylephrine followed by 1 μM acetylcholine. Treatment with lovastatin demonstrated no effect on the endothelium-independent vasoconstriction in response to phenylephrine (a). Treatment with lovastatin substantially preserved the endothelium-dependent vasodilation response. A one-way repeated measures ANOVA and a post-hoc Dunnett’s test with respect to Day 10 post-TNF-α showed that while TNF-α treatment reduced vasodilation in the absence of statin (*P < 0.05, **P < 0.005) relative to conditions not exposed to TNF- α or statin, lovastatin treatment blocked the effect of TNF-α on vasodilation (b).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 63 references

Cited by

Metadata

Authors
Fernandez, C. E., Yen, R. W., Perez, S. M., Bedell, H. W., Povsic, T. J., Reichert, W. M., & Truskey, G. A.
Affiliations
  • Duke University (US)
  • Duke Medical Center (US)
Corresponding author
Truskey, G. A.
Venue
Scientific Reports
Published
2016-02-18
Volume
6
Issue
1
Pages
21579-21579
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2283802589
Cited by
93
References
63
Citations by year
2026: 3 · 2025: 7 · 2024: 7 · 2023: 6 · 2022: 6 · 2021: 10 · 2020: 15 · 2019: 6 · 2018: 14 · 2017: 14 · 2016: 5
FWCI
6.27
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
Funders
  • American Heart Association
  • National Institutes of Health (UH2TR000505, UH3TR000505)
  • National Heart, Lung, and Blood Institute (R01HL044972)
  • National Institute of Biomedical Imaging and Bioengineering (R21EB017868)
  • National Center for Research Resources (P40RR017447)
  • National Center for Advancing Translational Sciences
  • Common Fund
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
Keywords
tissue-engineered blood vessels, in vitro drug testing, endothelialization, collagen gel, dermal fibroblasts, mesenchymal stem cells, nitric oxide, vasoconstriction, vasodilation, L-NAME, TNF-α, inflammation, caffeine, theophylline, lovastatin, drug toxicity testing
MeSH terms
Acetylcholine, Blood Vessels, Cells, Cultured, Drug Evaluation, Preclinical, Fibroblasts, Humans, Lovastatin, Nitric Oxide, Phenylephrine, Tumor Necrosis Factor-alpha, Vasoconstriction, Vasodilation, NG-Nitroarginine Methyl Ester, Tissue Engineering

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.